Cancer in women with infertility

Current Opinion in Obstetrics and Gynecology

Volumn 10, Issue 3, 1998, Pages 199-203

  Duckitt, Kirsten ^a   Templeton, Allan A ^b  

^a ROYAL COLLEGE OF OBSTETRICIANS AND GYNAECOLOGISTS   (United Kingdom)

^b ABERDEEN MATERNITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOMIFENE CITRATE;

BREAST CANCER; CANCER RISK; DOSE TIME EFFECT RELATION; ENDOMETRIUM CANCER; FEMALE; FEMALE INFERTILITY; HUMAN; OVARY CANCER; OVULATION INDUCTION; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; FEMALE; FERTILITY AGENTS, FEMALE; GENITAL NEOPLASMS, FEMALE; HUMANS; INFERTILITY, FEMALE; OVARIAN NEOPLASMS;

EID: 0031800142     PISSN: 1040872X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001703-199806000-00004     Document Type: Review

References (46)

1. Ron E, Lununfeld B, Menczer J, Blumstein T, Katz L, Oelsner G, Serr D. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125:780-790.
2. Brinton LA, Melton LJ III, Malkasian GDJ, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129:712-722.
3. Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990; 132:708-716.
4. Bamford PN, Steele SJ. Uterine and ovarian carcinoma in a patient receiving gonadotrophin therapy. Case report. Br J Obstet Gynaecol 1982 89:962-964.
5. Carter ME, Joyce DN. Ovarian carcinoma in a patient hyperstimulated by gonadotrophin therapy for in vitro fertilisation: a case report. J In Vitro Fertil Embryo Trans 1987; 4:126-128.
6. Burger CW, Nijman HW, Baak JPA, Schats R, Vermorken JB, Schoemaker J, Kenemans P. Borderline tumor of the ovary (BTO) and controlled hyperstimulation, a report of two cases. Hum Reprod 1993; 8:144.
7. Artini PG, Fasciani A, Cela V, Battaglia C, De Micheroux AA, D'ambrogio G, Genazzani AR. Fertility drugs and ovarian cancer. Gynecol Oncol 1997; 11:59-68. A review of all published case reports of ovarian cancer in connection with fertility drugs with a useful examination of how fertility drugs might fit into established theories on the pathogenesis of ovarian cancer.
8. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346:995-1000.
9. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotrophin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65:13-18.
10. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumours in a cohort of infertile women. N Engl J Med 1994; 331:771-776.
11. Whittemore AS, Harris R, Itnyre J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136:1184-1203.
12. Fathalla MF. Incessant ovulation-a factor in ovarian neoplasia. Lancet 1971; ii:163.
13. Stadel BV. The etiology and prevention of ovarian cancer. Am J Obstet Gynecol 1975; 123:772-774.
14. Daly MB. The epidemiology of ovarian cancer. Hematol Oncol Clin North Am 1992; 6:729-738.
15. Del Priore G, Robischon K, Phipps WR. Risk of ovarian cancer after treatment for infertility. N Engl J Med 1995; 332:1300.
16. Shapiro S. Risk of ovarian cancer after treatment for infertility. N Engl J Med 1995; 332:1301.
17. Bristow RE, Karlan BY. Ovulation induction, infertility, and ovarian cancer risk. Fertil Steril 1996; 66:449-507.
18. Paulson RJ. Fertility drugs and ovarian epithelial cancer: is there a link? J Assist Reprod Genet 1996; 13:751-756.
19. Mosgaard BJ, Lidegaard O, Andersen AN. The impact of parity, infertility and treatment with fertility drugs on the risk of ovarian cancer. Acta Obstet Gynecol Scand 1997; 76:89-95. A comprehensive review of epidemiological studies covering the relationship between parity, infertility and ovarian cancer with a critique of methodological problems encountered in the studies looking at the connection of fertility drugs with ovarian cancer.
20. Meirow D, Schenker JG. The link between female infertility and cancer: epidemiology and possible aetiologies. Hum Reprod Update 1996; 2:63-75.
21. Kaufman SC, Spirtas R, Alexander NJ. Do fertility drugs cause ovarian tumors? J Womens Health 1995; 4:247-259.
22. Whittemore AS, Harris R, Itnyre J, Halpern J, Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. I. Methods. Am J Epidemiol 1992; 136:1175-1183.
23. Harris R, Whittemore AS, Itnyre J. Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies III. Epithelial tumours of low malignant potential in white women. Am J Epidemiol 1992; 136:1204-1211.
24. Parazzini F, Negri E, La Vecchia C, Moroni S, Franceschi S, Crosignani PG. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod 1997; 12:2159-2161. An Italian case-control study which found no association between the use of fertility drugs and the risk of ovarian cancer.
25. Parazzini F, Negri E, La Vecchia C, Restelli C, Franceschi S. Family history of reproductive cancers and ovarian cancer risk: an Italian case-control study. Am J Epidemiol 1992; 135:35-40.
26. Mosgaard BJ, Lidegaard O, Kjaer SK , Schou G, Andersen AN. Infertility, fertility drugs, and invasive ovarian cancer: a case-control study. Fertil Steril 1997; 67:1005-1012. A Danish case control study which found no association between the use of fertility drugs and the risk of ovarian cancer, but found successful fertility treatment to be protective to the infertile woman.
27. Wu ML, Whittemore AS, Paffenbarger RSJ, Sarles DL, Kampert JB, Grosser S, et al. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and contraceptive usage. Am J Epidemiol 1988; 128:1216-1227.
28. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. 'Incessant ovulation' and ovarian cancer. Lancet 1979; ii:170-173.
29. Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984; 119:705-713.
30. Hildreth NG, Kelsey JL, Livolsi VA, Fischer DB, Holford TR, Mostow ED, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114:398-405.
31. Joly DJ, Lilienfeld AM, Diamond EL, Bross ID. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol 1974; 99:190-209.
32. McGowan L, Parent L, Lednar W, Norris HJ. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979; 7:325-344.
33. Adami HO, Hsieh CC, Lambe M, Trichopoulos D, Leon D, Persson I, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 334:1250-1254.
34. Rosen B, Shapiro H, Reynolds K, Robinson G, Thomas J, Murphy J. The feasibility of assessing women's perceptions of the risks and benefits of fertility drug therapy in relation to ovarian cancer risk. Fertil Steril 1997; 68:90-94. A pilot study assessing patients' knowledge of the issues surrounding fertility drugs and ovarian cancer. The study shows that most women are prepared to accept increased risks of ovarian cancer in return for the chance to conceive.
35. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983; 61:403-407.
36. Cowan LD, Gordis L, Tonascia JA, Jones GS. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981; 114:209-217.
37. Le MG, Bachelot A, Hill C. Characteristics of reproductive life and risk of breast cancer in a case-control study of young nulliparous women. J Clin Epidemiol 1989; 42:1227-1233.
38. Vessey MP, Mcpherson K, Roberts MM, Neil A, Jones L. Fertility in relation to the risk of breast cancer. Br J Cancer 1985; 52:625-628.
39. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort in infertile women. Gynecol Oncol 1996; 60:3-7.
40. Braga C, Negri E, La Vecchia C, Parazzini F, Dal Maso L, Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod 1996; 11:300-303.
41. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. In situ and invasive cervical carcinoma in a cohort of infertile women. Fertil Steril 1996; 65:19-22.
42. Kelsey JL, Livolsi VA, Holford TR, Fischer DB, Mostow ED, Schwartz PE, et al. A case control study of cancer of the endometrium. Am J Epidemiol 1982; 116:333-342.
43. Brinton LA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, et al. Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. Am J Obstet Gynecol 1992; 167:1317-1325.
44. Escobedo LG, Lee NC, Peterson HB, Wingo PA. Infertility associated endometrial cancer risk may be limited to specific groups of infertile women. Obstet Gynecol 1991; 77:124-128.
45. Morgan RW. Risk of endometrial cancer after tamoxifen treatment. Oncology 1997; 11:25-33.
46. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Res 1995; 5:123-127.